Trial NCT02169271

Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules

This randomized phase II trial studies acetylsalicylic acid compared to placebo in treating
high-risk patients with subsolid lung nodules. A nodule is a growth or lump that may be
malignant (cancer) or benign (not cancer). Chemoprevention is the use of drugs to keep cancer
from forming or coming back. The use of acetylsalicylic acid may keep cancer from forming in
patients with subsolid lung nodules.

Intervention

Aspirin, Laboratory Biomarker Analysis, Placebo

Condition

Current Smoker, Former Smoker, Multiple Pulmonary Nodules, Tobacco Use Disorder

Investigators

See list of participating sites